Article Excerpt: On March 27, Geisel School of Medicine professor Nicholas Jacobson published the results of the first clinical trial evaluating the effectiveness of a generative artificial intelligence psychotherapy chatbot.
The study, which tested the effects of “Therabot” on symptoms of anxiety, depression and eating disorders, showed significant improvements among participants — comparable to outcomes seen in traditional in-person therapy. Jacobson sat down with The Dartmouth to discuss the potential of AI in mental health care, ethical considerations in digital therapy and what’s next for Therabot.
Full Article: https://tinyurl.com/3s3mk6ye
Article Source: The Dartmouth